Navigation Links
Sagent Pharmaceuticals Announces Extension of Series A Financing
Date:5/20/2009

SCHAUMBURG, Ill., May 20 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced today that it has raised $30 million in a second Series A financing extension with pre-existing and new strategic investors. The round was again led by Vivo Ventures. This capital will be used to support upcoming product launches, development activities and strategic business objectives.

"Sagent's business model unites extensive pharmaceutical development, regulatory and manufacturing capabilities with the unique strength of our U.S. focused sales and marketing team to provide our hospital and clinical customers with a broad range of the highest quality injectable products," said Jeffrey M. Yordon, chief executive officer, founder and chairman of the board of Sagent Pharmaceuticals. "Since our inception in 2006, Sagent has successfully executed its strategy by filing more than 70 aNDAs to date, with more than 20 products expected in the market by year end. We appreciate our investors' continued confidence and commitment to Sagent."

About Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals, founded in 2006, is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients. Sagent currently has more than 200 products in development.

To Discover Injectables Excellence(TM) and learn more about Sagent, please visit www.SagentPharma.com.


'/>"/>
SOURCE Sagent Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Sagent Pharmaceuticals Inc. Completes $53 Million Series A Financing
2. Sagent Pharmaceuticals Launches Ciprofloxacin Injection, USP, 5% Dextrose Premix Bag
3. Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP
4. Sagent Pharmaceuticals Announces Presentations at Upcoming Lazard Capital Markets and Piper Jaffray Healthcare Conferences
5. Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... The report “Laboratory Information System/LIS Market ... SaaS), End User Labs (Clinical, Molecular Diagnostic, Blood ... - Global Forecast to 2019” provides a detailed ... current market trends, and strategies impacting the LIS ... the revenue and market growth. , Browse 85 ...
(Date:11/26/2014)... 26, 2014 Increasing demand for ... image guided surgeries has paved way for consequent ... incidence of various types of cancers and cardiac ... in demand for these owing to their use ... media injectors market can also be attributed to ...
(Date:11/26/2014)... Gone are the days when throngs of ... Friday, which signifies the beginning of the Christmas shopping season. ... carts in the comfort of their homes or on the ... is going to be an occasion with one of the ... $2.48 billion in revenue for online retailers according to Adobe ...
(Date:11/26/2014)... 2014 With a redesign of the ... Meier has enhanced the user experience and functionality ... patients an online destination for orthopedic and sports medicine ... the new and improved version of the website. ... than ever for current and prospective patients to find ...
(Date:11/26/2014)... November 26, 2014 Sonru, the video ... new Chief Operating Officer and Chief Marketing Officer, in ... office. , Jeff Jones has been appointed as ... who takes the role of Chief Marketing Officer. , ... executive whose 25-year career includes senior roles with The ...
Breaking Medicine News(10 mins):Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:2014 Best Friday Deals Revealed by Top10InAction 2Health News:Los Angeles Orthopedic Surgeon Dr. Steven Meier Announces Relaunch Of Practice Website 2Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2
... , WEDNESDAY, Nov. 2 (HealthDay News) -- The legalization ... that it will increase the availability and appeal of ... such link. For the study, Rhode Island Hospital ... Massachusetts between 1997 and 2009. Rhode Island legalized medical ...
... a biological mechanism that could help explain how tobacco products ... of abusing cocaine and perhaps other drugs as well, according ... the National Institutes of Health. The study is the first ... the behavioral effects of cocaine. The gateway drug ...
... By Lisa Esposito HealthDay Reporter , WEDNESDAY, ... in for a rude awakening: 13 percent of area high ... 10 has either forwarded, sent or posted sexually suggestive, explicit ... cellphone or online. So found a study of more ...
... yet done of the ancient history of insect-borne disease concludes ... to the New World, but it has been present ... monkeys. The findings, presented in a recent issue ... University, are based on the study of insect specimens preserved ...
... , WEDNESDAY, Nov. 2 (HealthDay News) -- Obese teens who ... it in the most healthy or effective ways, according to ... trying to drop the pounds don,t seem to fully understand ... 44,000 adolescents who participated in the Philadelphia Youth Risk ...
... per cent of the population of Denmark. The figure has ... at the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), ... the reasons. "In our study of over 400 ... different bacteria in their rectums and the risk of development ...
Cached Medicine News:Health News:NIH study examines nicotine as a gateway drug 2Health News:Teen 'Sexting' Common and Linked to Psychological Woes 2Health News:Teen 'Sexting' Common and Linked to Psychological Woes 3Health News:Teen 'Sexting' Common and Linked to Psychological Woes 4Health News:Analysis reveals malaria, other diseases as ancient, adaptive and persistent foes 2Health News:Analysis reveals malaria, other diseases as ancient, adaptive and persistent foes 3Health News:Overweight Teens Don't Seem to Grasp Weight Loss Rules 2Health News:Overweight Teens Don't Seem to Grasp Weight Loss Rules 3Health News:Dirt prevents allergy 2
(Date:11/26/2014)... and NEW YORK and ... -- As the leading distributor of market intelligence, MarketResearch.com ... research report by IQ4I Research and Consultancy focusing on ... learn more about IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 ... Active Pharmaceutical Ingredients Global Market – Forecast to 2020 ...
(Date:11/26/2014)... Nov. 25, 2014  Medtronic,s roughly $43 ... been widely discussed in the media for its ... a stronger leading player in one of the ... The healthcare market research firm said  the two ... a diverse set of solutions spanning inpatient to ...
(Date:11/26/2014)... 2014  Breckenridge Pharmaceutical, Inc. announced today that ... with Pii (Pharmaceutics International, Inc.) ( Hunt ... Pii expect to develop and commercialize several new ... will develop, manufacture and supply the products, and ... its own label.  The drugs, comprised of four ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2
... Jan. 12, 2011 CredenceHealth announced today ... for Meaningful Use in Clinical Quality Measures (i.e. eMeasures). ... receive this stand-alone certification. " CCHIT ... so that companies are now able to offer these ...
... INDIANAPOLIS, Jan. 12, 2011 Eli Lilly and Company ... and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee voted ... enzyme replacement therapy (PERT), currently under FDA review for ... During the meeting, the committee had questions about ...
Cached Medicine Technology:CredenceHealth's CHlive Meaningful Use Certified (ONC-ATCB 2011/2012 Certification) 2CredenceHealth's CHlive Meaningful Use Certified (ONC-ATCB 2011/2012 Certification) 3Statement From Lilly on FDA Advisory Committee Recommendation Regarding Liprotamase New Drug Application for Treatment of Exocrine Pancreatic Insufficiency 2
Mac Pherson titanium tying forceps are ergonomic, very thin, angled with tying platforms. Round ergonomic design for great balance and feel. Fine platforms excellent for tying 10-0 suture....
Harms tying forceps, standard, straight with smooth jaws. For 7-0 to 9-0 sutures....
Anis tying forcep is extra delicate with smooth jaws, curved. For 9-0 to 11-0 sutures....
Straight heavy shafts with 7 mm tying surface. Wide serrated handle, polished finish. Overall length 4.2 inches....
Medicine Products: